

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-myosin filament sliding (GO:0033275) | 6.74551883 |
| 2 | muscle filament sliding (GO:0030049) | 6.74551883 |
| 3 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.93309044 |
| 4 | skeletal muscle contraction (GO:0003009) | 5.92444922 |
| 5 | creatine metabolic process (GO:0006600) | 5.87555367 |
| 6 | protoporphyrinogen IX metabolic process (GO:0046501) | 5.81567119 |
| 7 | actin-mediated cell contraction (GO:0070252) | 5.39089615 |
| 8 | regulation of skeletal muscle contraction (GO:0014819) | 5.26732365 |
| 9 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 5.22672274 |
| 10 | lysine metabolic process (GO:0006553) | 4.93094584 |
| 11 | lysine catabolic process (GO:0006554) | 4.93094584 |
| 12 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.84943393 |
| 13 | oxygen transport (GO:0015671) | 4.82555305 |
| 14 | L-phenylalanine catabolic process (GO:0006559) | 4.56559222 |
| 15 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.56559222 |
| 16 | L-phenylalanine metabolic process (GO:0006558) | 4.40694398 |
| 17 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.40694398 |
| 18 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.39711859 |
| 19 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.33451662 |
| 20 | striated muscle contraction (GO:0006941) | 4.32906875 |
| 21 | porphyrin-containing compound biosynthetic process (GO:0006779) | 4.32762936 |
| 22 | actin filament-based movement (GO:0030048) | 4.31279377 |
| 23 | kynurenine metabolic process (GO:0070189) | 4.28662204 |
| 24 | myofibril assembly (GO:0030239) | 4.28308293 |
| 25 | gas transport (GO:0015669) | 4.27018958 |
| 26 | alpha-linolenic acid metabolic process (GO:0036109) | 4.22903770 |
| 27 | 2-oxoglutarate metabolic process (GO:0006103) | 4.16961422 |
| 28 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.14171318 |
| 29 | aromatic amino acid family catabolic process (GO:0009074) | 4.12112758 |
| 30 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.11086320 |
| 31 | NADH metabolic process (GO:0006734) | 4.08265225 |
| 32 | skeletal muscle adaptation (GO:0043501) | 3.96444102 |
| 33 | glyoxylate metabolic process (GO:0046487) | 3.92266793 |
| 34 | tetrapyrrole biosynthetic process (GO:0033014) | 3.92205930 |
| 35 | mannose metabolic process (GO:0006013) | 3.84630406 |
| 36 | cysteine metabolic process (GO:0006534) | 3.83114075 |
| 37 | indolalkylamine catabolic process (GO:0046218) | 3.79850679 |
| 38 | tryptophan catabolic process (GO:0006569) | 3.79850679 |
| 39 | indole-containing compound catabolic process (GO:0042436) | 3.79850679 |
| 40 | glycogen catabolic process (GO:0005980) | 3.78499760 |
| 41 | aspartate family amino acid catabolic process (GO:0009068) | 3.72633065 |
| 42 | regulation of cholesterol homeostasis (GO:2000188) | 3.71319888 |
| 43 | urea cycle (GO:0000050) | 3.70427491 |
| 44 | urea metabolic process (GO:0019627) | 3.70427491 |
| 45 | response to muscle activity (GO:0014850) | 3.69601955 |
| 46 | sarcomere organization (GO:0045214) | 3.68669295 |
| 47 | bile acid biosynthetic process (GO:0006699) | 3.68543261 |
| 48 | glucan catabolic process (GO:0009251) | 3.67014534 |
| 49 | heme biosynthetic process (GO:0006783) | 3.66756764 |
| 50 | positive regulation of myotube differentiation (GO:0010831) | 3.66450616 |
| 51 | plasma lipoprotein particle assembly (GO:0034377) | 3.64986847 |
| 52 | porphyrin-containing compound metabolic process (GO:0006778) | 3.63876906 |
| 53 | skeletal muscle fiber development (GO:0048741) | 3.63084683 |
| 54 | regulation of relaxation of muscle (GO:1901077) | 3.62857144 |
| 55 | carnitine shuttle (GO:0006853) | 3.61786448 |
| 56 | amino-acid betaine metabolic process (GO:0006577) | 3.58532188 |
| 57 | fatty acid transmembrane transport (GO:1902001) | 3.58125856 |
| 58 | negative regulation of fibrinolysis (GO:0051918) | 3.57434518 |
| 59 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.56244747 |
| 60 | tryptophan metabolic process (GO:0006568) | 3.53092652 |
| 61 | cardiac muscle contraction (GO:0060048) | 3.52895924 |
| 62 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.52424475 |
| 63 | high-density lipoprotein particle remodeling (GO:0034375) | 3.51431475 |
| 64 | cellular polysaccharide catabolic process (GO:0044247) | 3.49356669 |
| 65 | negative regulation of cell size (GO:0045792) | 3.49345401 |
| 66 | regulation of triglyceride catabolic process (GO:0010896) | 3.48736293 |
| 67 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.46921539 |
| 68 | protein-lipid complex assembly (GO:0065005) | 3.45581036 |
| 69 | erythrocyte development (GO:0048821) | 3.45455638 |
| 70 | regulation of protein activation cascade (GO:2000257) | 3.44828986 |
| 71 | cellular ketone body metabolic process (GO:0046950) | 3.43369655 |
| 72 | response to mercury ion (GO:0046689) | 3.42010509 |
| 73 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.41606203 |
| 74 | complement activation, alternative pathway (GO:0006957) | 3.39993867 |
| 75 | valine metabolic process (GO:0006573) | 3.39113934 |
| 76 | regulation of response to osmotic stress (GO:0047484) | 3.38476904 |
| 77 | phospholipid efflux (GO:0033700) | 3.37873954 |
| 78 | nitrogen cycle metabolic process (GO:0071941) | 3.35375647 |
| 79 | glutamate metabolic process (GO:0006536) | 3.34775590 |
| 80 | phospholipid homeostasis (GO:0055091) | 3.34400480 |
| 81 | cardiac myofibril assembly (GO:0055003) | 3.32921905 |
| 82 | oxaloacetate metabolic process (GO:0006107) | 3.31789236 |
| 83 | ethanol oxidation (GO:0006069) | 3.31726315 |
| 84 | response to methylmercury (GO:0051597) | 3.28849809 |
| 85 | sulfur amino acid catabolic process (GO:0000098) | 3.26172406 |
| 86 | regulation of fibrinolysis (GO:0051917) | 3.26011450 |
| 87 | plasma membrane repair (GO:0001778) | 3.23395582 |
| 88 | negative regulation of necroptotic process (GO:0060546) | 3.22264951 |
| 89 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.21737150 |
| 90 | polysaccharide catabolic process (GO:0000272) | 3.21254881 |
| 91 | regulation of complement activation (GO:0030449) | 3.20930311 |
| 92 | protein carboxylation (GO:0018214) | 3.18351117 |
| 93 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.18351117 |
| 94 | fructose metabolic process (GO:0006000) | 3.17573465 |
| 95 | striated muscle adaptation (GO:0014888) | 3.17562676 |
| 96 | response to inactivity (GO:0014854) | 3.17237123 |
| 97 | bile acid metabolic process (GO:0008206) | 3.17221308 |
| 98 | carnitine transmembrane transport (GO:1902603) | 3.16153749 |
| 99 | positive regulation of lipid catabolic process (GO:0050996) | 3.15996332 |
| 100 | negative regulation of sterol transport (GO:0032372) | 3.15782314 |
| 101 | negative regulation of cholesterol transport (GO:0032375) | 3.15782314 |
| 102 | muscle contraction (GO:0006936) | 3.14873944 |
| 103 | fatty acid beta-oxidation (GO:0006635) | 3.14512510 |
| 104 | short-chain fatty acid metabolic process (GO:0046459) | 3.14285447 |
| 105 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.11875958 |
| 106 | heme metabolic process (GO:0042168) | 3.11076331 |
| 107 | regulation of fatty acid oxidation (GO:0046320) | 3.10298748 |
| 108 | acetyl-CoA metabolic process (GO:0006084) | 3.10249278 |
| 109 | amino-acid betaine transport (GO:0015838) | 3.09697727 |
| 110 | carnitine transport (GO:0015879) | 3.09697727 |
| 111 | carnitine metabolic process (GO:0009437) | 3.09691839 |
| 112 | cardiac muscle hypertrophy (GO:0003300) | 3.08099872 |
| 113 | regulation of cholesterol esterification (GO:0010872) | 3.08017756 |
| 114 | alpha-amino acid catabolic process (GO:1901606) | 3.07296997 |
| 115 | serine family amino acid catabolic process (GO:0009071) | 3.07268979 |
| 116 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.06722020 |
| 117 | triglyceride homeostasis (GO:0070328) | 3.06289039 |
| 118 | acylglycerol homeostasis (GO:0055090) | 3.06289039 |
| 119 | reverse cholesterol transport (GO:0043691) | 3.05876558 |
| 120 | tricarboxylic acid metabolic process (GO:0072350) | 3.05790180 |
| 121 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.05677575 |
| 122 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.05677575 |
| 123 | positive regulation of fatty acid oxidation (GO:0046321) | 3.02462824 |
| 124 | plasma lipoprotein particle remodeling (GO:0034369) | 3.00542508 |
| 125 | protein-lipid complex remodeling (GO:0034368) | 3.00542508 |
| 126 | macromolecular complex remodeling (GO:0034367) | 3.00542508 |
| 127 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.98938551 |
| 128 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.98938551 |
| 129 | cholesterol efflux (GO:0033344) | 2.96328048 |
| 130 | erythrocyte maturation (GO:0043249) | 2.96034222 |
| 131 | myotube cell development (GO:0014904) | 2.95977906 |
| 132 | fatty acid oxidation (GO:0019395) | 2.95360872 |
| 133 | ketone body metabolic process (GO:1902224) | 2.94837763 |
| 134 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.94553363 |
| 135 | hemoglobin metabolic process (GO:0020027) | 2.92669589 |
| 136 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.92002398 |
| 137 | actomyosin structure organization (GO:0031032) | 2.91350166 |
| 138 | striated muscle hypertrophy (GO:0014897) | 2.91113892 |
| 139 | cellular modified amino acid catabolic process (GO:0042219) | 2.89064271 |
| 140 | lipid oxidation (GO:0034440) | 2.88425778 |
| 141 | fatty acid catabolic process (GO:0009062) | 2.88325338 |
| 142 | plasma lipoprotein particle organization (GO:0071827) | 2.87218060 |
| 143 | cellular hyperosmotic response (GO:0071474) | 2.86035413 |
| 144 | focal adhesion assembly (GO:0048041) | 2.85154293 |
| 145 | cell-substrate adherens junction assembly (GO:0007045) | 2.85154293 |
| 146 | plasma lipoprotein particle clearance (GO:0034381) | 2.85111400 |
| 147 | monocarboxylic acid catabolic process (GO:0072329) | 2.85084954 |
| 148 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.84844255 |
| 149 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.84243890 |
| 150 | regulation of necroptotic process (GO:0060544) | 2.83765044 |
| 151 | gluconeogenesis (GO:0006094) | 2.82876735 |
| 152 | muscle system process (GO:0003012) | 2.82305966 |
| 153 | striated muscle atrophy (GO:0014891) | 2.81847635 |
| 154 | cellular amino acid catabolic process (GO:0009063) | 2.81519787 |
| 155 | complement activation, classical pathway (GO:0006958) | 2.81289858 |
| 156 | protein-lipid complex subunit organization (GO:0071825) | 2.80967511 |
| 157 | homocysteine metabolic process (GO:0050667) | 2.80758926 |
| 158 | aromatic amino acid family metabolic process (GO:0009072) | 2.79530741 |
| 159 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.79022556 |
| 160 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.76548238 |
| 161 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.74416234 |
| 162 | glycogen metabolic process (GO:0005977) | 2.73500093 |
| 163 | muscle hypertrophy in response to stress (GO:0003299) | 2.71991198 |
| 164 | cardiac muscle adaptation (GO:0014887) | 2.71991198 |
| 165 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.71991198 |
| 166 | glucan metabolic process (GO:0044042) | 2.71613099 |
| 167 | cellular glucan metabolic process (GO:0006073) | 2.71613099 |
| 168 | glycogen biosynthetic process (GO:0005978) | 2.69866918 |
| 169 | glucan biosynthetic process (GO:0009250) | 2.69866918 |
| 170 | muscle adaptation (GO:0043500) | 2.68768113 |
| 171 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.68690766 |
| 172 | negative regulation of cell killing (GO:0031342) | 2.68690766 |
| 173 | hexose biosynthetic process (GO:0019319) | 2.67272119 |
| 174 | muscle hypertrophy (GO:0014896) | 2.66773670 |
| 175 | regulation of myotube differentiation (GO:0010830) | 2.61905093 |
| 176 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.60465037 |
| 177 | embryonic process involved in female pregnancy (GO:0060136) | 2.60072810 |
| 178 | monosaccharide biosynthetic process (GO:0046364) | 2.57700838 |
| 179 | protein targeting to plasma membrane (GO:0072661) | 2.54361391 |
| 180 | regulation of gamma-delta T cell activation (GO:0046643) | 2.52208797 |
| 181 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.51690122 |
| 182 | negative regulation of necrotic cell death (GO:0060547) | 2.51299235 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.59121940 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.65398372 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.30535139 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.66584108 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.41762601 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.13839055 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.96767888 |
| 8 | GATA1_22025678_ChIP-Seq_K562_Human | 2.89062676 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.78218757 |
| 10 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.72448108 |
| 11 | GATA1_19941826_ChIP-Seq_K562_Human | 2.62439019 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.51107793 |
| 13 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.47249233 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.30793145 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 2.22774957 |
| 16 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.17142180 |
| 17 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.03149492 |
| 18 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.95402379 |
| 19 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.94685680 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.93743780 |
| 21 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.91067828 |
| 22 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.86998260 |
| 23 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.81035103 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.79245858 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.77211846 |
| 26 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.75700426 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.74670125 |
| 28 | GATA2_19941826_ChIP-Seq_K562_Human | 1.71014900 |
| 29 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.67178415 |
| 30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.66687557 |
| 31 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.65304114 |
| 32 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.62764450 |
| 33 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.59100533 |
| 34 | MAF_26560356_Chip-Seq_TH1_Human | 1.56244593 |
| 35 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.52681528 |
| 36 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.52632334 |
| 37 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.51456491 |
| 38 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.50995936 |
| 39 | UTX_26944678_Chip-Seq_JUKART_Human | 1.49970112 |
| 40 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.47440835 |
| 41 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.46049634 |
| 42 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.43178120 |
| 43 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.42989097 |
| 44 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.42543071 |
| 45 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.42346036 |
| 46 | KDM2B_26808549_Chip-Seq_K562_Human | 1.41814407 |
| 47 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.40243326 |
| 48 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.38578559 |
| 49 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.37620643 |
| 50 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.36785474 |
| 51 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.32891142 |
| 52 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.32120199 |
| 53 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.29877647 |
| 54 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.29709651 |
| 55 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.28947514 |
| 56 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28757443 |
| 57 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.28242424 |
| 58 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.27324623 |
| 59 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.25770995 |
| 60 | * P68_20966046_ChIP-Seq_HELA_Human | 1.25715639 |
| 61 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.24285682 |
| 62 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.23330733 |
| 63 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.23330733 |
| 64 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.22046606 |
| 65 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.21002834 |
| 66 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.19616959 |
| 67 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.19160814 |
| 68 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.18790199 |
| 69 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.18705845 |
| 70 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18550169 |
| 71 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.18060611 |
| 72 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.17647877 |
| 73 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.17387619 |
| 74 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15652230 |
| 75 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.15628267 |
| 76 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15223341 |
| 77 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.15034987 |
| 78 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.13653703 |
| 79 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.13598133 |
| 80 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.13238752 |
| 81 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.11908779 |
| 82 | SA1_27219007_Chip-Seq_Bcells_Human | 1.11753160 |
| 83 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.11149511 |
| 84 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.09214290 |
| 85 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.08995107 |
| 86 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.08692426 |
| 87 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.07394626 |
| 88 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06881156 |
| 89 | SPI1_23127762_ChIP-Seq_K562_Human | 1.06868905 |
| 90 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.06725580 |
| 91 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.06079373 |
| 92 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.06042850 |
| 93 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.05854304 |
| 94 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04900330 |
| 95 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.04097132 |
| 96 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.03991025 |
| 97 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.03535425 |
| 98 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02916295 |
| 99 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.02738644 |
| 100 | MAF_26560356_Chip-Seq_TH2_Human | 1.02215542 |
| 101 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.01363237 |
| 102 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.00255649 |
| 103 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.00041280 |
| 104 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.98917785 |
| 105 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.97585698 |
| 106 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.97180021 |
| 107 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.96813017 |
| 108 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.96202502 |
| 109 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.94545476 |
| 110 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.94192788 |
| 111 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92680719 |
| 112 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91349691 |
| 113 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.90683963 |
| 114 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.90593349 |
| 115 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.89834246 |
| 116 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88821416 |
| 117 | MYB_26560356_Chip-Seq_TH1_Human | 0.88523989 |
| 118 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.87957614 |
| 119 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.87931097 |
| 120 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.87083529 |
| 121 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.85635525 |
| 122 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.85247141 |
| 123 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.84448106 |
| 124 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83306881 |
| 125 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.82740509 |
| 126 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.82197066 |
| 127 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.81161936 |
| 128 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.81149735 |
| 129 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.80506874 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.22584738 |
| 2 | MP0005360_urolithiasis | 4.93068826 |
| 3 | MP0005451_abnormal_body_composition | 4.76908339 |
| 4 | MP0003656_abnormal_erythrocyte_physiolo | 4.55802676 |
| 5 | MP0005365_abnormal_bile_salt | 4.16023739 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.92761085 |
| 7 | MP0005083_abnormal_biliary_tract | 3.37919197 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.04799144 |
| 9 | MP0004147_increased_porphyrin_level | 2.95417715 |
| 10 | MP0003252_abnormal_bile_duct | 2.88524759 |
| 11 | MP0002837_dystrophic_cardiac_calcinosis | 2.70800122 |
| 12 | MP0003646_muscle_fatigue | 2.65413357 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.59387780 |
| 14 | MP0009840_abnormal_foam_cell | 2.25868911 |
| 15 | MP0004130_abnormal_muscle_cell | 2.16907868 |
| 16 | MP0008260_abnormal_autophagy | 2.01886660 |
| 17 | MP0000750_abnormal_muscle_regeneration | 2.00628418 |
| 18 | MP0005058_abnormal_lysosome_morphology | 1.96137896 |
| 19 | MP0000751_myopathy | 1.96046103 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 1.93362071 |
| 21 | MP0003806_abnormal_nucleotide_metabolis | 1.88950347 |
| 22 | MP0000609_abnormal_liver_physiology | 1.85097607 |
| 23 | MP0000749_muscle_degeneration | 1.82029079 |
| 24 | MP0001666_abnormal_nutrient_absorption | 1.77154931 |
| 25 | MP0000733_abnormal_muscle_development | 1.72763780 |
| 26 | MP0004036_abnormal_muscle_relaxation | 1.64683168 |
| 27 | MP0005332_abnormal_amino_acid | 1.62189677 |
| 28 | MP0002118_abnormal_lipid_homeostasis | 1.61981440 |
| 29 | MP0002138_abnormal_hepatobiliary_system | 1.60333656 |
| 30 | MP0004215_abnormal_myocardial_fiber | 1.59097330 |
| 31 | MP0003172_abnormal_lysosome_physiology | 1.58267119 |
| 32 | MP0009278_abnormal_bone_marrow | 1.52149539 |
| 33 | MP0001661_extended_life_span | 1.50504607 |
| 34 | MP0005319_abnormal_enzyme/_coenzyme | 1.47465439 |
| 35 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.45290315 |
| 36 | MP0005330_cardiomyopathy | 1.44720221 |
| 37 | MP0008961_abnormal_basal_metabolism | 1.40724063 |
| 38 | MP0004084_abnormal_cardiac_muscle | 1.40658294 |
| 39 | MP0002269_muscular_atrophy | 1.38833660 |
| 40 | MP0006036_abnormal_mitochondrial_physio | 1.38363179 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.37539474 |
| 42 | MP0004087_abnormal_muscle_fiber | 1.37276221 |
| 43 | MP0003436_decreased_susceptibility_to | 1.36901083 |
| 44 | MP0000747_muscle_weakness | 1.36508357 |
| 45 | MP0005670_abnormal_white_adipose | 1.36254066 |
| 46 | MP0003868_abnormal_feces_composition | 1.34680051 |
| 47 | MP0003705_abnormal_hypodermis_morpholog | 1.32843146 |
| 48 | MP0006138_congestive_heart_failure | 1.29950980 |
| 49 | MP0003195_calcinosis | 1.28705260 |
| 50 | MP0004145_abnormal_muscle_electrophysio | 1.26476497 |
| 51 | MP0000685_abnormal_immune_system | 1.25102191 |
| 52 | MP0003221_abnormal_cardiomyocyte_apopto | 1.23526931 |
| 53 | MP0002822_catalepsy | 1.22785234 |
| 54 | MP0008775_abnormal_heart_ventricle | 1.21311285 |
| 55 | MP0005076_abnormal_cell_differentiation | 1.15756068 |
| 56 | MP0005666_abnormal_adipose_tissue | 1.14808004 |
| 57 | MP0002108_abnormal_muscle_morphology | 1.13170215 |
| 58 | MP0000604_amyloidosis | 1.11936490 |
| 59 | MP0003828_pulmonary_edema | 1.11550408 |
| 60 | MP0005636_abnormal_mineral_homeostasis | 1.09995271 |
| 61 | MP0004510_myositis | 1.09494824 |
| 62 | MP0003329_amyloid_beta_deposits | 1.08148190 |
| 63 | MP0003011_delayed_dark_adaptation | 1.05671562 |
| 64 | MP0005620_abnormal_muscle_contractility | 1.04248825 |
| 65 | MP0009643_abnormal_urine_homeostasis | 1.04026023 |
| 66 | MP0005409_darkened_coat_color | 1.02173144 |
| 67 | MP0003879_abnormal_hair_cell | 1.02062479 |
| 68 | MP0000013_abnormal_adipose_tissue | 1.00200506 |
| 69 | MP0004858_abnormal_nervous_system | 1.00149181 |
| 70 | MP0002909_abnormal_adrenal_gland | 0.99870735 |
| 71 | MP0010630_abnormal_cardiac_muscle | 0.99182850 |
| 72 | MP0002078_abnormal_glucose_homeostasis | 0.98074078 |
| 73 | MP0001849_ear_inflammation | 0.98038435 |
| 74 | MP0004233_abnormal_muscle_weight | 0.97417678 |
| 75 | MP0001764_abnormal_homeostasis | 0.97114926 |
| 76 | MP0002971_abnormal_brown_adipose | 0.96878075 |
| 77 | MP0005266_abnormal_metabolism | 0.95886213 |
| 78 | MP0003303_peritoneal_inflammation | 0.95067424 |
| 79 | MP0005535_abnormal_body_temperature | 0.95054024 |
| 80 | MP0000759_abnormal_skeletal_muscle | 0.93632474 |
| 81 | MP0004859_abnormal_synaptic_plasticity | 0.92422748 |
| 82 | MP0000598_abnormal_liver_morphology | 0.92280797 |
| 83 | MP0005551_abnormal_eye_electrophysiolog | 0.91802377 |
| 84 | MP0002972_abnormal_cardiac_muscle | 0.91214970 |
| 85 | MP0009764_decreased_sensitivity_to | 0.90452698 |
| 86 | MP0005464_abnormal_platelet_physiology | 0.87673928 |
| 87 | MP0003045_fibrosis | 0.87017241 |
| 88 | MP0004019_abnormal_vitamin_homeostasis | 0.86334478 |
| 89 | MP0002106_abnormal_muscle_physiology | 0.86308935 |
| 90 | MP0004484_altered_response_of | 0.86265183 |
| 91 | MP0008874_decreased_physiological_sensi | 0.86026684 |
| 92 | MP0005334_abnormal_fat_pad | 0.85883642 |
| 93 | MP0004185_abnormal_adipocyte_glucose | 0.84140073 |
| 94 | MP0005375_adipose_tissue_phenotype | 0.83228557 |
| 95 | MP0005387_immune_system_phenotype | 0.81585504 |
| 96 | MP0001790_abnormal_immune_system | 0.81585504 |
| 97 | MP0002166_altered_tumor_susceptibility | 0.81583764 |
| 98 | MP0002127_abnormal_cardiovascular_syste | 0.81578972 |
| 99 | MP0001544_abnormal_cardiovascular_syste | 0.80009085 |
| 100 | MP0005385_cardiovascular_system_phenoty | 0.80009085 |
| 101 | MP0009763_increased_sensitivity_to | 0.79227589 |
| 102 | MP0006035_abnormal_mitochondrial_morpho | 0.78935030 |
| 103 | MP0003763_abnormal_thymus_physiology | 0.75610160 |
| 104 | MP0008569_lethality_at_weaning | 0.75391651 |
| 105 | MP0004085_abnormal_heartbeat | 0.75272816 |
| 106 | MP0001800_abnormal_humoral_immune | 0.73099466 |
| 107 | MP0003566_abnormal_cell_adhesion | 0.72976288 |
| 108 | MP0002332_abnormal_exercise_endurance | 0.72229247 |
| 109 | MP0009642_abnormal_blood_homeostasis | 0.72212762 |
| 110 | MP0008469_abnormal_protein_level | 0.71594760 |
| 111 | MP0001765_abnormal_ion_homeostasis | 0.71395468 |
| 112 | MP0008872_abnormal_physiological_respon | 0.70083190 |
| 113 | MP0003137_abnormal_impulse_conducting | 0.70023603 |
| 114 | MP0010368_abnormal_lymphatic_system | 0.69179017 |
| 115 | MP0005025_abnormal_response_to | 0.67917767 |
| 116 | MP0002419_abnormal_innate_immunity | 0.67692628 |
| 117 | MP0004947_skin_inflammation | 0.67072658 |
| 118 | MP0002398_abnormal_bone_marrow | 0.64703971 |
| 119 | MP0008438_abnormal_cutaneous_collagen | 0.64429433 |
| 120 | MP0000003_abnormal_adipose_tissue | 0.63656764 |
| 121 | MP0002928_abnormal_bile_duct | 0.63112491 |
| 122 | MP0000689_abnormal_spleen_morphology | 0.62778565 |
| 123 | MP0003075_altered_response_to | 0.62636094 |
| 124 | MP0004381_abnormal_hair_follicle | 0.62052894 |
| 125 | MP0001545_abnormal_hematopoietic_system | 0.61895978 |
| 126 | MP0005397_hematopoietic_system_phenotyp | 0.61895978 |
| 127 | MP0002132_abnormal_respiratory_system | 0.60848483 |
| 128 | MP0009333_abnormal_splenocyte_physiolog | 0.59405567 |
| 129 | MP0001915_intracranial_hemorrhage | 0.57735983 |
| 130 | MP0004270_analgesia | 0.57572084 |
| 131 | MP0005369_muscle_phenotype | 0.56713803 |
| 132 | MP0002722_abnormal_immune_system | 0.55968084 |
| 133 | MP0003866_abnormal_defecation | 0.55858760 |
| 134 | MP0003091_abnormal_cell_migration | 0.54631834 |
| 135 | MP0000266_abnormal_heart_morphology | 0.52699088 |
| 136 | MP0000858_altered_metastatic_potential | 0.52604691 |
| 137 | MP0002249_abnormal_larynx_morphology | 0.50999728 |
| 138 | MP0005166_decreased_susceptibility_to | 0.50779092 |
| 139 | MP0009931_abnormal_skin_appearance | 0.49588831 |
| 140 | MP0002396_abnormal_hematopoietic_system | 0.48708716 |
| 141 | MP0000678_abnormal_parathyroid_gland | 0.48566389 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 7.49645639 |
| 2 | Nemaline bodies (HP:0003798) | 7.28809135 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.19018889 |
| 4 | Type 1 muscle fiber predominance (HP:0003803) | 6.03241320 |
| 5 | Myopathic facies (HP:0002058) | 5.75020444 |
| 6 | Poikilocytosis (HP:0004447) | 5.68798027 |
| 7 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.61691931 |
| 8 | Deep venous thrombosis (HP:0002625) | 4.57468449 |
| 9 | Reticulocytosis (HP:0001923) | 4.43871798 |
| 10 | Cholelithiasis (HP:0001081) | 4.37373930 |
| 11 | Acanthocytosis (HP:0001927) | 4.17883830 |
| 12 | EMG: myopathic abnormalities (HP:0003458) | 4.10192307 |
| 13 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.05413282 |
| 14 | Muscle fiber splitting (HP:0003555) | 4.02797029 |
| 15 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.98704574 |
| 16 | Abnormal gallbladder morphology (HP:0012437) | 3.97434918 |
| 17 | Ulnar deviation of the wrist (HP:0003049) | 3.92439271 |
| 18 | Hypochromic microcytic anemia (HP:0004840) | 3.88425740 |
| 19 | Distal arthrogryposis (HP:0005684) | 3.88384983 |
| 20 | Exercise-induced myalgia (HP:0003738) | 3.85435637 |
| 21 | Hyperbilirubinemia (HP:0002904) | 3.80148270 |
| 22 | Round ear (HP:0100830) | 3.79677475 |
| 23 | Xanthomatosis (HP:0000991) | 3.72698394 |
| 24 | Increased variability in muscle fiber diameter (HP:0003557) | 3.71730479 |
| 25 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.59833972 |
| 26 | Intrahepatic cholestasis (HP:0001406) | 3.54525200 |
| 27 | Ketosis (HP:0001946) | 3.45167672 |
| 28 | Distal lower limb muscle weakness (HP:0009053) | 3.39088324 |
| 29 | Myoglobinuria (HP:0002913) | 3.33001171 |
| 30 | Hyperlipoproteinemia (HP:0010980) | 3.32595959 |
| 31 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.24330104 |
| 32 | Neck muscle weakness (HP:0000467) | 3.18331319 |
| 33 | Distal lower limb amyotrophy (HP:0008944) | 3.16945343 |
| 34 | Complement deficiency (HP:0004431) | 3.11559968 |
| 35 | Abnormal gallbladder physiology (HP:0012438) | 3.09892853 |
| 36 | Cholecystitis (HP:0001082) | 3.09892853 |
| 37 | Ketoacidosis (HP:0001993) | 3.02709635 |
| 38 | Exercise-induced muscle cramps (HP:0003710) | 3.00157158 |
| 39 | Hyperammonemia (HP:0001987) | 2.98922834 |
| 40 | Hypoalphalipoproteinemia (HP:0003233) | 2.97296920 |
| 41 | Hypobetalipoproteinemia (HP:0003563) | 2.92122115 |
| 42 | Hypoglycemic coma (HP:0001325) | 2.91293122 |
| 43 | Dysmetric saccades (HP:0000641) | 2.90590822 |
| 44 | Abnormality of the calf musculature (HP:0001430) | 2.89935680 |
| 45 | Sudden death (HP:0001699) | 2.86944128 |
| 46 | Abnormality of the gallbladder (HP:0005264) | 2.79204921 |
| 47 | Rimmed vacuoles (HP:0003805) | 2.77723496 |
| 48 | Prolonged partial thromboplastin time (HP:0003645) | 2.76529638 |
| 49 | Hypolipoproteinemia (HP:0010981) | 2.73730614 |
| 50 | Calcaneovalgus deformity (HP:0001848) | 2.69999354 |
| 51 | Malignant hyperthermia (HP:0002047) | 2.60681005 |
| 52 | Difficulty climbing stairs (HP:0003551) | 2.60440305 |
| 53 | EMG: neuropathic changes (HP:0003445) | 2.58277981 |
| 54 | Insomnia (HP:0100785) | 2.57435986 |
| 55 | Hyporeflexia of lower limbs (HP:0002600) | 2.55490709 |
| 56 | Abnormality of the common coagulation pathway (HP:0010990) | 2.53844778 |
| 57 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.50644121 |
| 58 | Asymmetric septal hypertrophy (HP:0001670) | 2.49419025 |
| 59 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.48146638 |
| 60 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.45898151 |
| 61 | Polycythemia (HP:0001901) | 2.45172727 |
| 62 | Spinal rigidity (HP:0003306) | 2.44598772 |
| 63 | Hepatocellular carcinoma (HP:0001402) | 2.43564656 |
| 64 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.42710021 |
| 65 | Bulbar palsy (HP:0001283) | 2.42460845 |
| 66 | Joint hemorrhage (HP:0005261) | 2.42320716 |
| 67 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.38235910 |
| 68 | Gout (HP:0001997) | 2.37937303 |
| 69 | Frequent falls (HP:0002359) | 2.36347058 |
| 70 | Metabolic acidosis (HP:0001942) | 2.33555086 |
| 71 | Epidermoid cyst (HP:0200040) | 2.31438214 |
| 72 | Lower limb amyotrophy (HP:0007210) | 2.29497658 |
| 73 | Progressive muscle weakness (HP:0003323) | 2.27987219 |
| 74 | Abnormality of the calcaneus (HP:0008364) | 2.26995319 |
| 75 | Deformed tarsal bones (HP:0008119) | 2.25873773 |
| 76 | Rhabdomyolysis (HP:0003201) | 2.25583145 |
| 77 | Generalized muscle weakness (HP:0003324) | 2.25191239 |
| 78 | Difficulty running (HP:0009046) | 2.24018264 |
| 79 | Hypercholesterolemia (HP:0003124) | 2.23954819 |
| 80 | Central scotoma (HP:0000603) | 2.22688225 |
| 81 | Calf muscle hypertrophy (HP:0008981) | 2.20197281 |
| 82 | Hyperglycinuria (HP:0003108) | 2.14977135 |
| 83 | Abnormality of complement system (HP:0005339) | 2.13570460 |
| 84 | Hemorrhage of the eye (HP:0011885) | 2.13297145 |
| 85 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.13256326 |
| 86 | Scapular winging (HP:0003691) | 2.12353767 |
| 87 | Global brain atrophy (HP:0002283) | 2.11458247 |
| 88 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.10325711 |
| 89 | Abnormality of the lower motor neuron (HP:0002366) | 2.09944560 |
| 90 | Bundle branch block (HP:0011710) | 2.08456434 |
| 91 | Myocardial infarction (HP:0001658) | 2.08031922 |
| 92 | Cerebral aneurysm (HP:0004944) | 2.07489894 |
| 93 | Areflexia of lower limbs (HP:0002522) | 2.05538906 |
| 94 | Abnormality of purine metabolism (HP:0004352) | 2.05217020 |
| 95 | Foot dorsiflexor weakness (HP:0009027) | 2.05037256 |
| 96 | Status epilepticus (HP:0002133) | 2.04942548 |
| 97 | Paralysis (HP:0003470) | 2.04888939 |
| 98 | Abnormality of glycine metabolism (HP:0010895) | 2.04804911 |
| 99 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.04804911 |
| 100 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.02015379 |
| 101 | Diaphragmatic weakness (HP:0009113) | 2.01616092 |
| 102 | Abnormality of reticulocytes (HP:0004312) | 2.01105056 |
| 103 | Hyperglycinemia (HP:0002154) | 1.99513167 |
| 104 | Neonatal onset (HP:0003623) | 1.98897981 |
| 105 | Abnormality of the fingertips (HP:0001211) | 1.98634649 |
| 106 | Slender build (HP:0001533) | 1.98148805 |
| 107 | Easy fatigability (HP:0003388) | 1.97792938 |
| 108 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.97741099 |
| 109 | Subaortic stenosis (HP:0001682) | 1.97741099 |
| 110 | Abnormality of the foot musculature (HP:0001436) | 1.97586876 |
| 111 | Mitral stenosis (HP:0001718) | 1.97231006 |
| 112 | Stridor (HP:0010307) | 1.96346397 |
| 113 | Achilles tendon contracture (HP:0001771) | 1.95265254 |
| 114 | Late onset (HP:0003584) | 1.95134130 |
| 115 | Hypochromic anemia (HP:0001931) | 1.92523618 |
| 116 | Generalized hyperpigmentation (HP:0007440) | 1.92505100 |
| 117 | Abnormality of the Achilles tendon (HP:0005109) | 1.91762576 |
| 118 | Papilloma (HP:0012740) | 1.91554733 |
| 119 | Verrucae (HP:0200043) | 1.91554733 |
| 120 | Atrioventricular block (HP:0001678) | 1.91026805 |
| 121 | Sensorimotor neuropathy (HP:0007141) | 1.90921320 |
| 122 | Increased connective tissue (HP:0009025) | 1.90341985 |
| 123 | Ventricular tachycardia (HP:0004756) | 1.89535993 |
| 124 | Abnormality of iron homeostasis (HP:0011031) | 1.86677427 |
| 125 | Delayed CNS myelination (HP:0002188) | 1.86162246 |
| 126 | Colitis (HP:0002583) | 1.85932826 |
| 127 | Ragged-red muscle fibers (HP:0003200) | 1.84623597 |
| 128 | Absent phalangeal crease (HP:0006109) | 1.83484285 |
| 129 | Dilated cardiomyopathy (HP:0001644) | 1.83000465 |
| 130 | Congenital stationary night blindness (HP:0007642) | 1.82191295 |
| 131 | Abnormality of the intrinsic pathway (HP:0010989) | 1.81961031 |
| 132 | Toxemia of pregnancy (HP:0100603) | 1.80650240 |
| 133 | Abnormality of methionine metabolism (HP:0010901) | 1.80458003 |
| 134 | Increased serum ferritin (HP:0003281) | 1.79205629 |
| 135 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.78165360 |
| 136 | Muscle stiffness (HP:0003552) | 1.78146049 |
| 137 | Death in childhood (HP:0003819) | 1.77544312 |
| 138 | Abnormality of nucleobase metabolism (HP:0010932) | 1.77482345 |
| 139 | Skin nodule (HP:0200036) | 1.77311693 |
| 140 | Heart block (HP:0012722) | 1.77012981 |
| 141 | Autoimmune thrombocytopenia (HP:0001973) | 1.75945840 |
| 142 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.75479079 |
| 143 | Myotonia (HP:0002486) | 1.75193101 |
| 144 | Dicarboxylic aciduria (HP:0003215) | 1.74779220 |
| 145 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.74779220 |
| 146 | Microcytic anemia (HP:0001935) | 1.73113614 |
| 147 | Abnormal atrioventricular conduction (HP:0005150) | 1.72476208 |
| 148 | Muscular dystrophy (HP:0003560) | 1.71470422 |
| 149 | Obstructive sleep apnea (HP:0002870) | 1.70010160 |
| 150 | Fatigue (HP:0012378) | 1.65096122 |
| 151 | Waddling gait (HP:0002515) | 1.60799877 |
| 152 | Gowers sign (HP:0003391) | 1.60377718 |
| 153 | Weak cry (HP:0001612) | 1.59187883 |
| 154 | Ankle clonus (HP:0011448) | 1.55889625 |
| 155 | Ulnar bowing (HP:0003031) | 1.55533153 |
| 156 | Limb-girdle muscle atrophy (HP:0003797) | 1.55060415 |
| 157 | Fetal akinesia sequence (HP:0001989) | 1.54845656 |
| 158 | Gastrointestinal infarctions (HP:0005244) | 1.54104155 |
| 159 | Eczematoid dermatitis (HP:0000976) | 1.52302773 |
| 160 | Lipoatrophy (HP:0100578) | 1.49594152 |
| 161 | Hyperkalemia (HP:0002153) | 1.48072232 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.59581410 |
| 2 | PRPF4B | 3.06255478 |
| 3 | PKN2 | 3.04812461 |
| 4 | MAP4K1 | 2.78328857 |
| 5 | MAP3K10 | 2.63996962 |
| 6 | TTN | 2.63413465 |
| 7 | SIK1 | 2.63351404 |
| 8 | ERN1 | 2.59222432 |
| 9 | BCKDK | 2.42529261 |
| 10 | FGFR4 | 2.40930985 |
| 11 | EEF2K | 2.16765153 |
| 12 | RIPK1 | 2.07106044 |
| 13 | SIK2 | 1.94234327 |
| 14 | MAP3K7 | 1.93502082 |
| 15 | TYK2 | 1.82226511 |
| 16 | TAOK1 | 1.67052920 |
| 17 | GRK6 | 1.66320289 |
| 18 | PHKG2 | 1.64827399 |
| 19 | PHKG1 | 1.64827399 |
| 20 | JAK1 | 1.54434621 |
| 21 | TAOK2 | 1.50511414 |
| 22 | SMG1 | 1.49169032 |
| 23 | PINK1 | 1.40929655 |
| 24 | MAPK11 | 1.40156807 |
| 25 | INSRR | 1.36139498 |
| 26 | MAP2K3 | 1.34836863 |
| 27 | TAOK3 | 1.32808521 |
| 28 | PTK6 | 1.31499213 |
| 29 | CAMK1G | 1.29996879 |
| 30 | TESK2 | 1.27176673 |
| 31 | SGK3 | 1.25635313 |
| 32 | PRKCH | 1.22404893 |
| 33 | FLT3 | 1.22248100 |
| 34 | JAK2 | 1.21963084 |
| 35 | DAPK2 | 1.21580600 |
| 36 | PIK3CG | 1.21512055 |
| 37 | MAP3K3 | 1.18826277 |
| 38 | OBSCN | 1.16873722 |
| 39 | MAPK12 | 1.16071906 |
| 40 | ICK | 1.14899504 |
| 41 | IRAK3 | 1.13932801 |
| 42 | MAP2K4 | 1.13059642 |
| 43 | PRKAA1 | 1.09129903 |
| 44 | LMTK2 | 1.08749385 |
| 45 | RIPK4 | 1.07710657 |
| 46 | CAMK1D | 1.07038522 |
| 47 | NEK1 | 1.02699197 |
| 48 | DMPK | 1.00768534 |
| 49 | STK38 | 0.99982713 |
| 50 | MAP3K13 | 0.99644471 |
| 51 | ZAP70 | 0.97331414 |
| 52 | CDK12 | 0.96458428 |
| 53 | PDK1 | 0.94131140 |
| 54 | SYK | 0.92763612 |
| 55 | STK4 | 0.89285121 |
| 56 | MAP3K6 | 0.89131466 |
| 57 | PRKAA2 | 0.86426043 |
| 58 | JAK3 | 0.86244182 |
| 59 | CDC42BPA | 0.86096322 |
| 60 | CAMKK1 | 0.85634220 |
| 61 | BLK | 0.83438377 |
| 62 | STK10 | 0.81474300 |
| 63 | RET | 0.81363335 |
| 64 | FGFR3 | 0.81162990 |
| 65 | TBK1 | 0.80014320 |
| 66 | ITK | 0.79814270 |
| 67 | MAPKAPK3 | 0.79630382 |
| 68 | PDK4 | 0.77821621 |
| 69 | PDK3 | 0.77821621 |
| 70 | PDPK1 | 0.77243595 |
| 71 | IKBKE | 0.76482950 |
| 72 | DYRK1B | 0.75418984 |
| 73 | PRKD3 | 0.74836194 |
| 74 | SGK2 | 0.74198637 |
| 75 | MARK2 | 0.72122146 |
| 76 | TNK2 | 0.69883803 |
| 77 | MAP2K6 | 0.69480601 |
| 78 | TRPM7 | 0.68535469 |
| 79 | EPHB1 | 0.67837103 |
| 80 | RPS6KL1 | 0.67664598 |
| 81 | RPS6KC1 | 0.67664598 |
| 82 | TGFBR2 | 0.66564228 |
| 83 | PAK6 | 0.65944860 |
| 84 | MAP3K4 | 0.64671596 |
| 85 | BMX | 0.64465960 |
| 86 | MUSK | 0.64420886 |
| 87 | MAPK7 | 0.63703667 |
| 88 | MAP2K2 | 0.63487722 |
| 89 | MTOR | 0.61068933 |
| 90 | FES | 0.60428458 |
| 91 | CSF1R | 0.60034759 |
| 92 | PRKD1 | 0.59220264 |
| 93 | KIT | 0.59139385 |
| 94 | MAP2K1 | 0.57863166 |
| 95 | MAP3K11 | 0.57621815 |
| 96 | CAMK4 | 0.53713805 |
| 97 | MAP3K14 | 0.53372614 |
| 98 | ARAF | 0.53131832 |
| 99 | ERBB2 | 0.51637878 |
| 100 | LRRK2 | 0.50956928 |
| 101 | RPS6KA6 | 0.50821634 |
| 102 | AKT2 | 0.50688048 |
| 103 | PRKD2 | 0.50578228 |
| 104 | HCK | 0.50051093 |
| 105 | SGK1 | 0.49028271 |
| 106 | MAP3K1 | 0.48740270 |
| 107 | KSR2 | 0.48702422 |
| 108 | CSK | 0.47305281 |
| 109 | KDR | 0.47230180 |
| 110 | RAF1 | 0.46954964 |
| 111 | BTK | 0.46448771 |
| 112 | STK11 | 0.45458744 |
| 113 | WNK1 | 0.45211648 |
| 114 | PRKACG | 0.45020917 |
| 115 | CDK6 | 0.44762492 |
| 116 | SGK223 | 0.43742280 |
| 117 | SGK494 | 0.43742280 |
| 118 | MOS | 0.43433355 |
| 119 | MARK3 | 0.43406431 |
| 120 | PIK3CA | 0.43319019 |
| 121 | PRKCQ | 0.43140376 |
| 122 | MAP3K5 | 0.42803701 |
| 123 | MAPK4 | 0.41759373 |
| 124 | EPHA3 | 0.41685533 |
| 125 | HIPK2 | 0.41639160 |
| 126 | LCK | 0.41242425 |
| 127 | IRAK4 | 0.41131158 |
| 128 | CDK4 | 0.39615359 |
| 129 | RPS6KA3 | 0.39458577 |
| 130 | FGR | 0.39373273 |
| 131 | RPS6KA2 | 0.38828560 |
| 132 | PDGFRA | 0.36942012 |
| 133 | PTK2B | 0.33217109 |
| 134 | RPS6KA1 | 0.31962934 |
| 135 | MAPK10 | 0.30793011 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.06922943 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.36778453 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.28358834 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.73332724 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.63791464 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.46023301 |
| 7 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.34711694 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.33375205 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 2.33368066 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.25668865 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.13177395 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.01936966 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.98930224 |
| 14 | ABC transporters_Homo sapiens_hsa02010 | 1.86358892 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84574123 |
| 16 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.84370063 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.80696267 |
| 18 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.78109541 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.76689884 |
| 20 | Bile secretion_Homo sapiens_hsa04976 | 1.75786161 |
| 21 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.72259843 |
| 22 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.68126991 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.64455336 |
| 24 | Lysine degradation_Homo sapiens_hsa00310 | 1.60236121 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.57728493 |
| 26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.52494225 |
| 27 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.48973727 |
| 28 | Carbon metabolism_Homo sapiens_hsa01200 | 1.40874596 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.34586747 |
| 30 | Peroxisome_Homo sapiens_hsa04146 | 1.33622936 |
| 31 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.33600229 |
| 32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.26163353 |
| 33 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.24863276 |
| 34 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19999909 |
| 35 | Insulin resistance_Homo sapiens_hsa04931 | 1.17897913 |
| 36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.14742260 |
| 37 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.11451021 |
| 38 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.08237090 |
| 39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.08041251 |
| 40 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.03150797 |
| 41 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.02912229 |
| 42 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.01044107 |
| 43 | Galactose metabolism_Homo sapiens_hsa00052 | 1.00982394 |
| 44 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.00860936 |
| 45 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.98105770 |
| 46 | Circadian rhythm_Homo sapiens_hsa04710 | 0.98079551 |
| 47 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.96621513 |
| 48 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.95820280 |
| 49 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.95504612 |
| 50 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.95014988 |
| 51 | Sulfur relay system_Homo sapiens_hsa04122 | 0.94491764 |
| 52 | Malaria_Homo sapiens_hsa05144 | 0.94420416 |
| 53 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.93089859 |
| 54 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92455469 |
| 55 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.90516070 |
| 56 | Endometrial cancer_Homo sapiens_hsa05213 | 0.90487878 |
| 57 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.89983708 |
| 58 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.88276993 |
| 59 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.88124194 |
| 60 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.87399118 |
| 61 | Prion diseases_Homo sapiens_hsa05020 | 0.86845962 |
| 62 | Glioma_Homo sapiens_hsa05214 | 0.86285662 |
| 63 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.86210141 |
| 64 | Long-term potentiation_Homo sapiens_hsa04720 | 0.84976557 |
| 65 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.84939502 |
| 66 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.84115080 |
| 67 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.81125764 |
| 68 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.79759334 |
| 69 | Bladder cancer_Homo sapiens_hsa05219 | 0.78257956 |
| 70 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.73531757 |
| 71 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.73323282 |
| 72 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.72578329 |
| 73 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.69810141 |
| 74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69710708 |
| 75 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.69607630 |
| 76 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.69257629 |
| 77 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.69033504 |
| 78 | Platelet activation_Homo sapiens_hsa04611 | 0.68296101 |
| 79 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.68044551 |
| 80 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67034962 |
| 81 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65588044 |
| 82 | Focal adhesion_Homo sapiens_hsa04510 | 0.64474678 |
| 83 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.64035499 |
| 84 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.63834282 |
| 85 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.63786180 |
| 86 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.63368388 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.62764368 |
| 88 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62749605 |
| 89 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.61949981 |
| 90 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61826521 |
| 91 | Amoebiasis_Homo sapiens_hsa05146 | 0.61708618 |
| 92 | Histidine metabolism_Homo sapiens_hsa00340 | 0.61586141 |
| 93 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.61565490 |
| 94 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61422262 |
| 95 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.61373377 |
| 96 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.61328676 |
| 97 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.59627981 |
| 98 | Retinol metabolism_Homo sapiens_hsa00830 | 0.58673342 |
| 99 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.58284575 |
| 100 | Phototransduction_Homo sapiens_hsa04744 | 0.56765056 |
| 101 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.54536184 |
| 102 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54142973 |
| 103 | Hepatitis C_Homo sapiens_hsa05160 | 0.53980377 |
| 104 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53976755 |
| 105 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.53800710 |
| 106 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.53496495 |
| 107 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.52109081 |
| 108 | Thyroid cancer_Homo sapiens_hsa05216 | 0.50898100 |
| 109 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.50806051 |
| 110 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.50248166 |
| 111 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.49968786 |
| 112 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.49856936 |
| 113 | Insulin secretion_Homo sapiens_hsa04911 | 0.48499603 |
| 114 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48186011 |
| 115 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.47621528 |
| 116 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.47462492 |
| 117 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.45877609 |
| 118 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.45470438 |
| 119 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44723735 |
| 120 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.43883138 |
| 121 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.43138317 |
| 122 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.41797098 |
| 123 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.38716047 |
| 124 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.37056729 |
| 125 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36361699 |
| 126 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.34614994 |
| 127 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.34008192 |
| 128 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.33237699 |
| 129 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.32658682 |
| 130 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.32605873 |
| 131 | Olfactory transduction_Homo sapiens_hsa04740 | 0.32154870 |
| 132 | Salivary secretion_Homo sapiens_hsa04970 | 0.31335171 |
| 133 | Circadian entrainment_Homo sapiens_hsa04713 | 0.28908315 |
| 134 | GABAergic synapse_Homo sapiens_hsa04727 | 0.28639777 |
| 135 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.28464744 |
| 136 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.28280054 |
| 137 | Renin secretion_Homo sapiens_hsa04924 | 0.28242648 |
| 138 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.27621091 |
| 139 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.27448042 |
| 140 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.27442264 |
| 141 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.22863644 |

